Balance Sheet	22-Sep	21-Sep	20-Sep
Total Assets	$ 352.75B	$ 351.00B	$ 323.89B
Current Assets	$ 135.41B	$ 134.84B	$ 143.71B
Cash, Cash Equivalents and Short-Term Investments	$ 48.30B	$ 62.64B	$ 90.94B
Receivables	$ 60.93B	$ 51.51B	$ 37.45B
Inventory	$ 4.95B	$ 6.58B	$ 4.06B
Prepaid Assets	0	0	0
Other Current Assets	$ 21.22B	$ 14.11B	$ 11.26B
Total Non Current Assets	$ 217.35B	$ 216.17B	$ 180.18B
Total Liabilities	$ 302.08B	$ 287.91B	$ 258.55B
Current Liabilities	$ 153.98B	$ 125.48B	$ 105.39B
Total Non Current Liabilities	$ 148.10B	$ 162.43B	$ 153.16B
Total Equity Gross Minority	$ 50.67B	$ 63.09B	$ 65.34B
Stockholders Equity	$ 50.67B	$ 63.09B	$ 65.34B
Total Capitalization	$ 149.63B	$ 172.20B	$ 164.01B

Income Statement	22-Sep	21-Sep	20-Sep
Total Revenue	$ 394.33B	$ 365.82B	$ 274.51B
Operating Revenue	$ 394.33B	$ 365.82B	$ 274.51B
Cost of Revenue	$ 223.55B	$ 212.98B	$ 169.56B
Gross Profit	$ 170.78B	$ 152.84B	$ 104.96B
Operating Expense	$ 51.34B	$ 43.89B	$ 38.67B
Operating Income	$ 119.44B	$ 108.95B	$ 66.29B
Net Non Operating Interest Income Expense	$ -334.00M	$ 198.00M	$ 890.00M
Other Income Expense	$ -7.50B	$ 60.00M	$ -87.00M
Pretax Income	$ 119.10B	$ 109.21B	$ 67.09B
Tax Provision	$ 19.30B	$ 14.53B	$ 9.68B
Net Income	$ 99.80B	$ 94.68B	$ 57.41B
Basic Average Shares	$ 16.22B	$ 16.70B	$ 17.35B
Diluted Average Shares	$ 16.33B	$ 16.86B	$ 17.53B
Dividend Per Share	0.9	0.85	0.8
Total Expenses	$ 274.89B	$ 256.87B	$ 208.23B
Net Income From Continuing And Discontinued Operation	$ 99.80B	$ 94.68B	$ 57.41B
Interest Expense	-	$ 2.65B	$ 2.87B
EBIT	$ 113.37B	$ 111.85B	$ 69.96B
EBITDA	$ 124.48B	$ 123.14B	$ 81.02B

Questions: compute the following metrics for the two most recent years:

a. Current ratio

b. Working capital

c. Acid test ratio

d. Inventory turnover

e. Days sales in receivables

f. Debt-to-equity ratio

g. Times-interest-earned

h. Asset turnover

i. Return on sales

j. Return on assets

k. Return on equity